Magic pivoted from a blood pressure coaching app to a more successful product after realizing their initial idea wasn't gaining traction.

After raising our seed round, we went on to raise about $20 million more in venture capital, taking our device through prototype stages and clinical studies, ultimately achieving FDA clearance.

Brex pivoted from a VR hardware headset idea to a credit card for startups, achieving product-market fit quickly and raising hundreds of millions in just two years.

Access to capital and FDA's development strategies for rare diseases have enabled small biotech companies to bring products to market without being acquired.

Brex pivoted from a VR headset idea to understanding the needs of other founders, which led them to develop a product that addressed real customer pain points.

We prefer to build products in-house but decided to acquire X1 to quickly enter the credit card space and offer a competitive product.

For medical devices, the MVP should be successfully peer-reviewed science that supports your work and outlines a clear path to regulatory clearance.

Launching Watsi on August 23, 2012, was initially underwhelming, but after posting on Hacker News, we quickly gained traction and funded all our medical treatments in our pipeline within hours.

Once you have a prototype and user interest, the next step is to build a Minimum Viable Product (MVP) that can be launched quickly, ideally within weeks.